1. 3215 Outcome of ABVD chemotherapy in an Australian population of Hodgkin lymphoma (HL). (September 2015) Authors: Jalali, A.; Ha, F.; Chong, G.; Grigg, A.; McKendrick, J.; Schwarer, A.; Doig, R.; Hamid, A.; Hawkes, E.A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S654 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Approach to thyroid cytology. Issue 4 (June 2015) Authors: Kumarasinghe, M. P.; Cummings, M. C.; Raymond, W.; Shield, P.; Judge, M.; Beaty, A.; Bethwaite, P.; Braye, S.; Carter, C. D.; Chong, G.; Downey, P.; Frost, F.; Loo, C.; Nga, M. E.; Nguyen, H.; Panicker, V.; Parker, A. J. C.; Phillips, G.; Salisbury, E.; Twin, J. Journal: Pathology Issue: Volume 47:Issue 4(2015:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Approach to thyroid cytology: rationale for standardisation. Issue 4 (June 2015) Authors: Kumarasinghe, M. P.; Cummings, M. C.; Raymond, W.; Shield, P.; Judge, M.; Beaty, A.; Bethwaite, P.; Braye, S.; Carter, C. D.; Chong, G.; Downey, P.; Frost, F.; Loo, C.; Nga, M. E.; Nguyen, H.; Panicker, V.; Parker, A. J. C.; Phillips, G.; Salisbury, E.; Twin, J. Journal: Pathology Issue: Volume 47:Issue 4(2015:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian population. (22nd November 2014) Authors: Castellsagué, E.; Liu, J.; Volenik, A.; Giroux, S.; Gagné, R.; Maranda, B.; Roussel‐Jobin, A.; Latreille, J.; Laframboise, R.; Palma, L.; Kasprzak, L.; Marcus, V.A.; Breguet, M.; Nolet, S.; El‐Haffaf, Z.; Australie, K.; Gologan, A.; Aleynikova, O.; Oros‐Klein, K.; Greenwood, C. Journal: Clinical genetics Issue: Volume 87:Number 6(2015:Jun.) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CLINICAL OUTCOMES AND MOLECULAR CHARACTERIZATION FROM a PHASE II STUDY OF COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. (June 2017) Authors: Lenz, G.; Hawkes, E.; Verhoef, G.; Haioun, C.; Lim, S.; Heo, D.; Ardeshna, K.; Chong, G.; Christensen, J.H.; Shi, V.; Lippert, S.; Hiemeyer, F.; Piraino, P.; Beckmann, G.; Peña, C.; Buvaylo, V.; Childs, B.H.; Gorbatchevsky, I.; Salles, G. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV‐8‐positive, HIV‐negative patient. (28th October 2016) Authors: Murphy, C.; Hawkes, E.; Chionh, F.; Chong, G. Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 42:Number 1(2017) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. RESULTS FROM THE SAFETY RUN‐IN PERIOD OF THE SYMPATICO STUDY EVALUATING IBRUTINIB IN COMBINATION WITH VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA. (12th June 2019) Authors: Wang, M.; Ramchandren, R.; Chen, R.; Karlin, L.; Chong, G.; Jurczak, W.; Wu, K.; Bishton, M.; Collins, G.; Eliadis, P.; Peyrade, F.; Freise, K.; Sukbuntherng, J.; Lee, Y.; Dobkowska, E.; Fedorov, V.; Neuenburg, J.; Tam, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0280 Rapamycin restores the balance between th17 and regulatory t cells in uspa patients. (12th June 2018) Authors: Jinnan, F.; Dan, X.; Chong, G.; Xiaofeng, L. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗